No Data
Encompass Health Poised for 'Solid Progress' on Development Front Due to Discharge Growth, Industry Demand, RBC Says
Encompass Health (EHC) is poised for "solid progress" on the development front as about 33% Q1 discharge growth came from new locations, RBC Capital Markets said in a note Tuesday. "During the quarter
6 Analysts Have This To Say About Encompass Health
6 analysts have expressed a variety of opinions on Encompass Health (NYSE:EHC) over the past quarter, offering a diverse set of opinions from bullish to bearish.The table below offers a condensed view
Encompass Health Price Target Raised to $95.00/Share From $83.00 by RBC Capital
Encompass Health Price Target Raised to $95.00/Share From $83.00 by RBC Capital
Encompass Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 10.77% RBC Capital $83 → $95 Maintains Outperform 04/26/2024 10.77% Raymond James $85 → $95 Rei
Encompass Health (EHC) Gets a Buy From RBC Capital
RBC Lifts Price Target on Encompass Health to $95 From $83, Cites 'Strong' Q1 Results, 2024 Guidance Boost; Outperform Kept
Encompass Health (EHC) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $94 to $108.